Nektar Therapeutics
NKTR· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $60.91M | $18.41M | $27.07M | $37.93M |
| Net Income | -$16.54M | -$43.55M | -$24.07M | -$8.71M |
| EPS Diluted | -$0.14 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.38 |
| -$0.21 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.